COMMUNIQUÉS West-GlobeNewswire

BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities
08/07/2026
Proposed acquisition of an Israeli company with approximately 20 years of operating experience is expected to strengthen BiomX's Detection-Analysis-Response strategy through security systems, fire detection, access [...]
Ontario’s Lung Cancer Screening Program Ranks Among World’s Best, but Half of Patients Are Still Diagnosed at Advanced Stages, New Report Finds
08/07/2026
Lung Health Foundation’s landmark baseline report shows a system with exceptional foundations – and critical blind spots in equity, patient experience, and access that could determine whether Ontario meets the Pan- [...]
Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees
08/07/2026
Urges Stockholders to Vote “FOR” ONLY Seer’s Director Nominees on the BLUE Proxy Card REDWOOD CITY, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”) today issued a letter to [...]
OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
08/07/2026
FDA alignment on a single-dose Phase 3 study design and potential single-trial registration pathway further strengthens the Company's clinical development program for urcosimod Company unveils NEPTUNE ( N europathic E [...]
CorVel Named 2026 PropertyCasualty360 Insurance Luminaries Winner for Excellence in Claims Management
08/07/2026
FORT WORTH, Texas, July 08, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a national provider of risk management solutions, today announced it has been named a 2026 PropertyCasualty360 Insurance Luminaries [...]
Vivani Medical conclut un accord avec Novo Nordisk pour évaluer le NPM-139, un implant miniature à base de sémaglutide à action ultra-prolongée destiné au traitement de l’obésité
08/07/2026
Novo Nordisk s’apprête à mener une évaluation interne non exclusive des implants à base de sémaglutide élaborés par Vivani ALAMEDA, Californie, 08 juill. 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq : VANI) (« [...]
Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval
08/07/2026
Serial entrepreneur Crosby has brought numerous implantable medical devices through CE marking, U.S. FDA approval and commercial launch Joins as Tensive approaches pivotal clinical and regulatory milestones for its [...]
Trimoryn Supplement Facts Analysis: Latest Safety Report Issued to Consumers About Ingredients' Effectiveness & Side Effects Risk
08/07/2026
Trimoryn issues a 2026 supplement facts and consumer safety update covering its weight management support formula, ingredient amounts, suggested use, side effects risk considerations, customer support details, and 60- [...]
AMSilk and Ajinomoto Foods Europe Expand Partnership to Enable Industrial-Scale Production of Silk Proteins
08/07/2026
NEURIED, Germany and NESLE, France, July 08, 2026 (GLOBE NEWSWIRE) -- AMSilk, a global leader in biotech produced silk materials, today announced a significant expansion of its partnership with Ajinomoto Foods Europe ( [...]
Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors
08/07/2026
LONDON and PHILADELPHIA, July 08, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION ® , a tumor-activated oncology [...]
On World Obesity Day, WONDERLAB Releases the Targeted Microbiota Weight Management White Paper
08/07/2026
SHENZHEN, China, July 08, 2026 (GLOBE NEWSWIRE) -- WONDERLAB, a leading Chinese probiotics company ranked No.1 in probiotic sales in China,¹ has published the Targeted Microbiota Weight Management White Paper, a strain- [...]
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
08/07/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 8, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
Dumbo Health Launches SleepLongevityAge, Bringing Clinical Care to the World’s Most Overlooked Health Metric
08/07/2026
Introducing Sleep Longevity: a new category of care that turns the world’s most overlooked health metric into action. Sleep better. Live longer. Miami, Florida, July 08, 2026 (GLOBE NEWSWIRE) -- Millions of people wake [...]
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
08/07/2026
$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash BURLINGTON, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Bone Biologics [...]
TaiMed Biologics (4147) Receives TFDA Drug License Collection Notice for Trogarzo, Marking the Final Step Toward Commercial Launch in Taiwan
08/07/2026
TAIPEI, July 07, 2026 (GLOBE NEWSWIRE) -- TaiMed Biologics (TPEX: 4147) announced today that its HIV therapy Trogarzo (ibalizumab; English name: Trogarzo Injection; Chinese name: 佐加洛注射劑) has officially received a Drug [...]
Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
07/07/2026
Initial $5.6 million provides immediate capital to accelerate commercialization of Lifeward's restorative healthcare platform; additional $5.6 million available upon achievement of defined commercial and financial [...]
AdCare Rhode Island Opens New Program to Support Recovery and Accountability Following Impaired Driving Offenses
07/07/2026
NORTH KINGSTOWN, R.I., July 07, 2026 (GLOBE NEWSWIRE) -- AdCare Rhode Island, a leading provider of addiction treatment in South County , has launched a new outpatient DUI/refusal program for eligible first- and second- [...]
Resmed Announces Agreement to Sell MatrixCare Business
07/07/2026
Sharpens Resmed’s focus on high-growth sleep and connected care markets SAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and [...]
ARS Pharmaceuticals Announces CEO Succession
07/07/2026
Richard Lowenthal, Chief Executive Officer, Transitioning following More than a Decade of Leadership Since Co-Founding the Company Donn Casale, President, Appointed Chief Executive Officer and Director SAN DIEGO, July [...]

Pages